| Ticker | Company | Market Cap | Price | Price Target | Upside/Downside | Top Analysts Upside/Downside | Consensus | Top Analysts Consensus | Analysts | Top Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| GSK | GSK PLC | $98.99B | $49.08 | N/A | N/A | N/A | N/A | -4.96% | -17.54% | 42.74% | 11.25% | |||
| BMY | BRISTOL MYERS SQUIBB CO | $111.23B | $54.64 | $52.86 | -3.26% | Hold | 7 | -3.42% | 25.40% | 61.29% | 11.74% | |||
| MRK | MERCK & CO INC | $265.03B | $106.78 | $111.63 | 4.54% | Buy | 8 | 4.02% | 10.50% | 51.83% | 20.74% | |||
| LLY | ELI LILLY & CO | $1.02T | $1,077.75 | $1.10k | 1.99% | Strong Buy | 16 | 15.08% | 25.87% | 180.92% | 37.45% | |||
| GRFS | GRIFOLS SA | $6.26B | $9.10 | $10.00 | 9.89% | Hold | 1 | 1.94% | 67.92% | 16.03% | 4.41% | |||
| AMGN | AMGEN INC | $179.28B | $332.93 | $323.78 | -2.75% | Hold | 9 | 2.42% | 21.11% | 131.71% | 14.05% | |||
| ABBV | ABBVIE INC | $406.46B | $229.98 | $254.00 | 10.44% | Strong Buy | 14 | 7.24% | 131.83% | -1,197.32% | 23.62% | |||
| GILD | GILEAD SCIENCES INC | $154.71B | $124.70 | $135.23 | 8.45% | Strong Buy | 13 | 3.37% | 13.26% | 59.22% | 21.79% | |||
| SNY | SANOFI | $122.45B | $48.47 | $58.00 | 19.66% | Strong Buy | 1 | 0.30% | 28.11% | 15.44% | 8.65% | |||
| JNJ | JOHNSON & JOHNSON | $500.24B | $207.63 | $210.79 | 1.52% | Buy | 14 | 4.37% | 6.18% | 40.56% | 16.68% | |||
| AMRN | AMARIN CORP PLC | $294.01M | $14.14 | N/A | N/A | N/A | N/A | -4.16% | N/A | 101.68% | 70.72% | |||
| AZN | ASTRAZENECA PLC | $287.99B | $92.90 | N/A | N/A | N/A | N/A | 5.15% | 56.34% | 44.53% | 17.85% | |||
| NVS | NOVARTIS AG | $268.06B | $139.18 | $118.00 | -15.22% | Strong Sell | 1 | 2.29% | 10.45% | 48.53% | 20.05% | |||
| OGN | ORGANON & CO | $1.87B | $7.18 | $9.50 | 32.31% | Strong Sell | 3 | -0.19% | 28.51% | 124.34% | 8.31% | |||
| SCLX | SCILEX HOLDING CO | $106.95M | $14.10 | N/A | N/A | N/A | N/A | 135.01% | N/A | -40.94% | 26.67% | |||
| PFE | PFIZER INC | $142.65B | $25.09 | $28.67 | 14.26% | Hold | 6 | -1.58% | 19.04% | 16.71% | 7.43% | |||
| BIIB | BIOGEN INC | $25.98B | $177.08 | $173.40 | -2.08% | Buy | 10 | -2.37% | 13.47% | 13.49% | 8.41% | |||
| MIRA | MIRA PHARMACEUTICALS INC | $63.23M | $1.51 | N/A | N/A | N/A | N/A | N/A | N/A | -101.84% | -100.72% | |||
| MDCX | MEDICUS PHARMA LTD | $34.48M | $1.57 | $27.00 | 1,625.24% | Strong Buy | 1 | N/A | N/A | N/A | -33.78% | |||
| NSRX | NASUS PHARMA LTD | N/A | $7.61 | $20.50 | 169.56% | Strong Buy | 2 | N/A | N/A | N/A | -1,512.47% |